glp-1 dose conversion Journal of Lancaster General Health Designing GLP-1 delivery: structural perspectives

Cardiovascular Risks While some GLP-1 drugs improve heart health, patients with existing heart conditions require close monitoring

Incretin-pathway research has advanced from single-receptor agonism toward multi-receptor strategies that interrogate energy balance, glucose handling, hepatic lipid flux, and satiety circuits in a coordinated fashion

Aunque estas preocupaciones requieren mayor cautela e investigacin, la evidencia actual sugiere que los beneficios generales del tratamiento simple con GLP-1 compensan los riesgos esperados para la mayora de las personas

Lithium deficiency and the onset of Alzheimers disease